Clinical Practice and Cases in Emergency Medicine
Emergent Treatment of Neuroleptic Malignant Syndrome Induced by Antipsychotic Monotherapy Using Dantrolene
- Author(s): Ngo, Vivian
- Guerrero, Alfredo
- Lanum, David
- Burgett-Moreno, Michelle
- Fenati, Gregory
- Barr, Steven
- Neeki, Michael M.
- et al.
Published Web Locationhttps://doi.org/10.5811/cpcem.2018.11.39667
Neuroleptic malignant syndrome (NMS) is a rare but potentially fatal complication resulting from neuroleptic drug therapy. Presentation of NMS can vary, and diagnosis relies primarily upon medical history and symptomatology. Due to the potential delay in diagnosis, emergency physicians should remain vigilant in recognizing the symptoms of NMS and be prepared to initiate immediate treatment following diagnosis. Dantrolene, which has been used for spasticity and malignant hyperthermia, has been reported as a potential treatment for NMS and led to off-label use for NMS. We report two cases of NMS induced by antipsychotic monotherapy for which dantrolene was administered.